| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |